Welcome to our dedicated page for Unitedhealth Gp SEC filings (Ticker: UNH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UnitedHealth Group Incorporated (UNH) provides extensive disclosure to investors and regulators through its SEC filings, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. These documents offer a detailed view of the company’s health care and well-being operations, which span UnitedHealthcare’s health benefit programs and Optum’s health services, technology and analytics businesses.
Annual and quarterly reports describe UnitedHealth Group’s consolidated financial condition and results of operations, as well as segment performance for UnitedHealthcare and Optum. They include information on revenues, earnings from operations, medical costs, operating costs, cash flows, capital structure and risk factors. Investors use these filings to understand how trends in medical utilization, Medicare and Medicaid funding, and pharmacy services affect the company’s financial profile.
Current reports on Form 8-K provide timely updates on material events. Recent 8-K filings have covered topics such as quarterly earnings releases, reaffirmation of earnings outlooks, amendments to bylaws to reflect changes in the company’s registered office and registered agent in Delaware, the appointment of new independent directors, and investor presentations. Some 8-K items are furnished under Regulation FD to share information discussed with investors and analysts, including earnings expectations and the impact of acquisitions like Amedisys.
UnitedHealth Group also files 8-Ks to document governance and leadership changes, including the appointment of directors with regulatory and clinical backgrounds. These filings often reference standard indemnification agreements and compensation arrangements for non-employee directors, providing additional transparency into board practices.
On this SEC filings page, users can review UnitedHealth Group’s regulatory disclosures in one place. Real-time updates from EDGAR ensure that new 10-K, 10-Q and 8-K filings, as well as any amendments, appear promptly. AI-powered summaries can help explain complex sections, highlight key metrics, and clarify the implications of items such as changes in outlook, medical cost trends or bylaw amendments. Investors can also monitor executive and director changes reported on Form 8-K and use the filings history to track how UnitedHealth Group’s strategy, capital management and risk profile evolve over time.
On June 26, 2025, UnitedHealth Group Incorporated (UNH) filed a Form 4 disclosing that director Kristen L. Gil acquired 7 shares of common stock on June 24, 2025. The acquisition was coded "A" and carried a price of $0 per share because the shares represent dividend equivalents paid on vested deferred stock units.
Following the transaction, Gil directly owns 1,558 shares and indirectly holds 3,800 shares through a trust. No derivative securities were reported. The transaction is routine and immaterial to UnitedHealth's float but modestly increases insider alignment with shareholders.
UnitedHealth Group Inc. (UNH) – Form 4 filing dated 26-Jun-2025
Director John H. Noseworthy reported the automatic acquisition of 42 shares of common stock on 24-Jun-2025. The shares represent dividend equivalents on previously vested deferred stock units and were credited at a transaction price of $0.00. Following this routine credit, Noseworthy’s direct ownership rises to 6,105 shares. No derivative transactions or dispositions were reported, and the filing indicates the transaction was not executed under a Rule 10b5-1 trading plan. The small share count and zero-cost basis signal an administrative, non-market purchase with limited impact on public float or insider sentiment.
UnitedHealth Group director Paul R. Garcia reported insider trading activity on June 24, 2025. The transaction involved the acquisition of 11 shares of Common Stock as dividend equivalents paid on vested deferred stock units, received at $0 price.
Following the transaction, Garcia's beneficial ownership consists of:
- 2,481 shares held directly
- 2,146 shares held indirectly through a Revocable Trust
- 45 shares held indirectly through Trust 2
- 55 shares held indirectly through Trust 3
The dividend equivalents were immediately vested and are subject to the same terms as the underlying deferred stock units. The Form 4 was filed by attorney-in-fact Faraz A. Choudhry on June 26, 2025.
UnitedHealth Group Inc. (UNH) filed a Form 4 reporting a routine ownership update for Christopher R. Zaetta, EVP & Chief Legal Officer. On 06/24/2025, Zaetta acquired 48.038 common shares at a stated price of $0, representing dividend-equivalent units credited on outstanding restricted stock units (RSUs). These dividend equivalents carry the same vesting conditions as the underlying RSUs and are forfeited if those units fail to vest. Following the credit, Zaetta’s direct beneficial ownership stands at 10,240.746 shares. No derivatives were reported, and there were no dispositions of shares.
UnitedHealth Group Inc. (UNH) – Form 4 filing, 26 Jun 2025: President & CFO John F. Rex reported an automatic acquisition of 131.931 common shares on 24 Jun 2025. The shares represent dividend-equivalent units credited on outstanding restricted stock units; no cash outlay was made (price = $0).
Following the credit, Rex directly owns 203,898.467 shares and indirectly owns 6,791 shares via a trust. No derivative transactions, open-market purchases, or sales were disclosed. The filing is routine and does not reflect a discretionary investment decision.
UnitedHealth Group Inc. (UNH) filed a Form 4 on 26-Jun-2025 detailing a minor insider transaction by Timothy J. Noel, Chief Executive Officer of UnitedHealthcare (a principal subsidiary).
On 24-Jun-2025, Noel acquired 47.823 shares of UNH common stock at $0.00 per share. The acquisition represents dividend-equivalent units automatically credited on outstanding restricted stock units (RSUs); these units carry the same vesting schedule as the underlying RSUs and will be forfeited if the RSUs do not vest. Following the credit, Noel’s direct beneficial ownership increased to 9,243.999 shares.
No open-market purchases, option exercises, or cash transactions occurred, and there was no use of a Rule 10b5-1 trading plan. The filing is procedural in nature, recording routine dividend accruals rather than an active investment decision by the insider.
UnitedHealth Group (UNH) – Form 4 insider transaction
Director Timothy P. Flynn reported the acquisition of 66 common shares on 06/24/2025. The shares represent dividend equivalents paid on previously vested deferred stock units and were received at $0 cost. After this transaction, Flynn’s holdings stand at 9,189 shares held directly and 6,033 shares held indirectly through a trust. The filing was submitted on 06/26/2025 by attorney-in-fact Faraz A. Choudhry.
UnitedHealth Group Inc. (UNH) Form 4 filing overview: Director Frederick William McNabb III reported the automatic acquisition of 53 shares of UnitedHealth common stock on 06/24/2025. The shares represent dividend-equivalent units paid on previously vested deferred stock units and were acquired at a stated price of $0.00 under the company’s equity plan.
Following the transaction, McNabb’s direct beneficial ownership increased to 13,709 shares. No derivative securities were bought or sold, and there were no dispositions. The filing was signed by attorney-in-fact Faraz A. Choudhry on 06/26/2025.
The transaction is routine, carries no cash outlay, and does not reflect an open-market purchase. It modestly increases the director’s equity alignment but is immaterial relative to UnitedHealth’s share count and market capitalization.
FAQ
What is the current stock price of Unitedhealth Gp (UNH)?
What is the market cap of Unitedhealth Gp (UNH)?
